First Time Loading...

Rosetta Genomics Ltd
OTC:ROSGQ

Watchlist Manager
Rosetta Genomics Ltd Logo
Rosetta Genomics Ltd
OTC:ROSGQ
Watchlist
Price: 0.0001 USD
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

ROSGQ Price Targets Summary
Rosetta Genomics Ltd

There are no price targets for ROSGQ.
ROSGQ Lowest Forecast
Wall Street Target
Not Available
ROSGQ Average Forecast
Wall Street Target
Not Available
ROSGQ Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Rosetta Genomics Ltd Competitors:
Price Targets
PHM
Pharma Mar SA
83% Upside
EXAI
Exscientia PLC
91% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
35% Upside
BIIB
Biogen Inc
41% Upside
PHM
Pharma Mar SA
83% Upside
EXAI
Exscientia PLC
91% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
35% Upside
BIIB
Biogen Inc
41% Upside
CRIS
Curis Inc
54% Upside
B
002038
Beijing SL Pharmaceutical Co Ltd
396% Upside
BIOG B
Biogaia AB
33% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside

Revenue
Forecast

Revenue Estimate
Rosetta Genomics Ltd

For the last 6 years the compound annual growth rate for Rosetta Genomics Ltd's revenue is 79%.

79%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Rosetta Genomics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Rosetta Genomics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
What are analyst estimates?

See Also

Summary
ROSGQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
ROSGQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ROSGQ stock valuation using valuation multiples.
Wall Street Estimates
ROSGQ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ROSGQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ROSGQ's stock price target?
Not Available

ROSGQ doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 132,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.